On March 25, Binhai Inv (02886) spent 42,200 Hong Kong dollars to repurchase 38,000 shares.

17:39 25/03/2026

Binhai Investment (02886) announced that the company repurchased 38,000 shares for HK$42,000 on March 25, 2026, with a repurchase price per share of HK$1.1-1.12.

BINHAI INV(02886) announced that on March 25, 2026, the company spent 42,000 Hong Kong dollars to repurchase 38,000 shares, with a repurchase price of 1.1-1.12 Hong Kong dollars per share.

Chuan Holding (01420) announces a profit surge. It is expected that the shareholders' net profit will increase significantly by approximately 132.9% in 2025.

NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.

China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.

Chuan Holding (01420) announces a profit surge. It is expected that the shareholders' net profit will increase significantly by approximately 132.9% in 2025.

NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.

China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.